← All trials
NCT05669560
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 20, 2023
- Primary completion
- May 30, 2027
- Completion date
- Jun 30, 2027
- First posted
- Jan 3, 2023
- Last posted
- Nov 22, 2023
- Enrollment
- 0
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of OklahomaLead sponsor
- University of OklahomaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.